Thu. Sep 19th, 2024

This is the initial issue of our Insight EU Monitoring of data issues around COVID 19. We will start monitoring the output of relevant EU, global, and national institutions regarding COVID-19 data monitoring.

You can scroll through this dossier in the PDF below and download it for free. You can also sign up for our daily Insight EU Digest to get notified of updates.


INTRODUCTION
  • Introductory comment: Why data are crucial to fight this COVID pandemic
EU DIGITAL COVID CERTIFICATE
  • The EU Digital COVID Certificate as Data Hub
WHO
  • WHO Coronavirus (COVID-19) Dashboard – Overview – Measures – Data Table
  • WHO Scientific Brief: COVID-19 natural immunity – 10 May 2021
EU COMMISSION
  • REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL pursuant to Article 16(1) of Regulation (EU) 2021/953 of the European Parliament and of the Council on a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (EU Digital COVID Certificate) to facilitate free movement during the COVID-19 pandemic
  • Speech by Commissioner Kyriakides at the EPSCO Health Council-Current and future Response to the Pandemic.
  • Statement by EU Commissioner Kyriakides following the meeting of the EPSCO Health Council.
EU JOINT RESEARCH CENTRE
  • Efficient tracing of Omicron with new PCR test – 13/12/2021
  • European COVID-19 In Vitro Diagnostic Devices and Test Methods Database
ECDC
  • ECDC publishes new risk assessment on further emergence of Omicron variant
  • Timely actions are needed to rapidly detect and control outbreaks in long-term care facilities – 9/12/2021
  • Guidance provided by the European Centre for Disease Prevention and Control Possible issuance of certificates of recovery based on rapid antigen test results – 18/10/2021
  • Possible issuance of certificates of recovery based on antibody test results – 18/10/2021
  • ECDC on the validity period of certificates of recovery – 18/10/2021
  • The use of antibody tests for SARS-COV-2 in the context of Digital Green Certificates – 20/5/2021
EMA
  • International regulators stress continued need for COVID-19 therapeutics
  • EMA and ECDC on “mix-and-match” vaccination courses against COVID-19
  • ICMRA high-level meeting on global health emergencies and regulatory approaches
EU PARLIAMENT
  • MOTION FOR A RESOLUTION on issuing COVID recovery certificates based on serological and antibody tests – 6/12/2021
  • EPP
    • The EPP Group puts COVID-19 therapeutics under the spotlight – 8/12/2021
    • EU-Abgeordnete Angelika Niebler (EVP/CSU) zu COVID-19 Therapien
  • ECR
    • Responding to Commission President Ursula Von Der Leyen’s call for a discussion on mandatory vaccination and digital certificates – ECR – 8/12/2021
EU COUNCIL
  • Documents from the EU Council Register
    • ST 14693 2021 INIT – NOTE – 07/12/2021 – Council Recommendation on a coordinated approach to facilitate safe free movement during the COVID-19 pandemic and replacing Recommendation (EU) 2020/1475 = Exchange of views
    • ST 14697 2021 INIT – NOTE – 03/12/2021 Proposal for a Council Recommendation on a coordinated approach to facilitate safe free movement during the COVID-19 pandemic and replacing Recommendation (EU) 2020/1475 – Presidency compromise text
    • ST 13967 2021 INIT – COVER NOTE – 25/11/2021 – Proposal for a COUNCIL RECOMMENDATION on a coordinated approach to facilitate safe free movement during the COVID-19 pandemic and replacing Recommendation (EU) 2020/1475
    • ST 13967 2021 ADD 1 – COVER NOTE – 25/11/2021 – ANNEX to the Proposal for a Council Recommendation on a coordinated approach to facilitate safe free movement during the COVID-19 pandemic and replacing Recommendation (EU) 2020/1475
    • ST 14691 2021 INIT – COVER NOTE – 06/12/2021 – Regulation of the European Parliament and of the Council on a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (EU Digital COVID Certificate) with regard to third-country nationals legally staying or residing in the territories of Member States during the COVID-19 pandemic – notification from Iceland
EU MEMBER STATES
  • GERMANY
    • Bundesrat stimmt verschärftem Infektionsschutzgesetz zu
INTERNATIONAL ORGANISATIONS
  • IMCRA
    • ICMRA statement for healthcare professionals: How COVID-19 vaccines will be regulated for safety and effectiveness
    • ICMRA COVID-19 Vaccine development: Future steps Workshop
    • ICMRA SARS-CoV-2 Vaccines Workshop #2 – Summary
SCIENCE
  • RKI – ROBERT KOCH INSTITUTE
    • RKI Situation reports from Monday to Friday
    • Seroepidemiological Studies in Germany
    • Seroepidemiological studies on SARS-CoV-2 in samples from the general population and blood donors in Germany – findings up to August 2021
    • STAKOB: Notes on the identification, diagnosis, and treatment of patients with COVID-19 – 16/7/2021
    • Nationwide Antibody Study “Living in Germany—Corona Monitoring” (RKI-SOEP)
  • PAUL EHRLICH INSTITUTE
    • Antikörper COVID-19-Geimpfter erkennen andere Strukturen des Spike-Proteins als Antikörper SARS-CoV-2-Infizierter
    • Omicron-Variante – Schutz nach Auffrischimpfung möglich – Paul-Ehrlich-Institut (PEI)
    • Antigen-Schnelltests auf SARS-CoV-2: vergleichende Sensitivitätsbewertung CE-gekennzeichneter Tests
  • LEOPOLDINA
    • Coronavirus-Pandemie: Klare und konsequente Maßnahmen – sofort!
  • INSTITUT FÜR MIKROBIOLOGIE DER BUNDESWEHR
    • Frequently Asked Questions on COVID-19 antibody detection
UNITED KINGDOM
  • Weekly National Influenza and COVID-19 Report
  • UK Government: Coronavirus (COVID-19): antibody testing
USA
  • Press Briefing by White House COVID-⁠19 Response Team and Public Health Official – 7/12/2021
  • U.S. CDC: Interim Guidelines for COVID-19 Antibody Testing
  • U.S. FDA: FAQs on Testing for SARS-CoV-2
  • U.S. FDA: Coronavirus Disease 2019 Testing Basics
RECENT SCIENTIFIC STUDIES
  • Antibody Levels Help Predict Immunity After COVID Shot
  • F. Buder et al. SARS-CoV-2 infectivity correlates with high viral loads and detection of viral antigen and is terminated by seroconversion. J Infect Dis 2021 aop.
  • S.M. Desantis et al. Estimation of Total Immunity to SARS-CoV-2 in Texas

You can scroll, buy and download the PDF below:




Important note

On this platform, we are publishing our Insight EU Monitoring editions with a delay of several hours. If you want to get our monitoring e-mails in real-time you can subscribe to our full-text services on our IEU Store page.

Please do not hesitate to reach out if you need tailored regulatory monitoring services, focusing on certain policy fields, institutions, or issues. See also our FAQs for further information.

Last, but not least, here are some more interesting deep links:

Forward to your friends